Drug Trial Radar · NCT06677996
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
Last checked: Nov 20, 2026Latest source record: May 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Nov 11, 2024
Primary completion
Dec 30, 2024
Study completion May 7, 2025
Sponsor
- Lead sponsor
- Immunome, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.
Conditions
- Healthy Volunteer
Interventions
varegacestatDrug
Experimental intervention
Itraconazole (200 mg)Drug
Intervention to evaluate DDI with experimental intervention
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effect of itraconazole on the PK of varegacestat in healthy participants.Time frame: Up to 5 weeks
- Effect of itraconazole on the PK of varegacestat in healthy participants.Time frame: Up to 5 weeks
- Effect of itraconazole on the PK of varegacestat in healthy participants.Time frame: Up to 5 weeks
- Effect of itraconazole on the PK of varegacestat in healthy participants.Time frame: Up to 5 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Tempe, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.